References
- FoaRRizzoSPetrellaFDe MariaFBellomiMRecurrent aggressive fibromatosis of the chest wallEcancermedicalscience2014846425368668
- HajjarWMAlShehriAFAlessaMAAl-NassarSALate presentation of aggressive fibromatosis involving head, neck and chest wallJ Coll Physicians Surg Pak2017271065465629056131
- LeeSHLeeHKSongJSJeongHSChest wall fibromatosis in the axillaArch Plast Surg201239217517722783521
- Martinez TruferoJPajares BernadITorres RamonIHernando CuberoJPazo CidRDesmoid-type fibromatosis: who, when, and how to treatCurr Treat Options Oncol20171852928439797
- SmithAJLewisJJMerchantNBLeungDHWoodruffJMBrennanMFSurgical management of intra-abdominal desmoid tumoursBr J Surg200087560861310792318
- ZhangYJGaoYSClinical features and surgical treatment of chest aggressive fibromatosisZhonghua Zhong Liu Za Zhi2016383232235 Chinese26988832
- YangSWangXJiangHWangYLiZLuHEffective treatment of aggressive fibromatosis with celecoxib guided by genetic testingCancer Biol Ther2017181075776028881160
- SkubitzKMBiology and treatment of aggressive fibromatosis or desmoid tumorMayo Clin Proc201792694796428578783
- SakaiTNishidaYHamadaSImmunohistochemical staining with non-phospho beta-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosisDiagn Pathol20171216628851389
- HofmanMSHicksRJHow we read oncologic FDG PET/CTCancer Imaging20161613527756360
- HainSFCurranKMBeggsADFogelmanIO’DohertyMJMaiseyMNFDG-PET as a “metabolic biopsy” tool in thoracic lesions with indeterminate biopsyEur J Nucl Med20012891336134011585292
- HaratiKJaenischABehrBEffect of surgical margins on prognosis in aggressive fibromatosis: a single-institutional analysis of 90 patientsOncol Lett20171455129513429113152
- JanssenMLvan BroekhovenDLCatesJMMeta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosisBr J Surg2017104434735728199014
- PenelNLe CesneABonvalotSSurgical versus non-surgical approach in primary desmoid-type fibromatosis patients: a nationwide prospective cohort from the French Sarcoma GroupEur J Cancer20178312513128735069
- ZloteckiRAScarboroughMTMorrisCGExternal beam radiotherapy for primary and adjuvant management of aggressive fibromatosisInt J Radiat Oncol Biol Phys200254117718112182989
- ScheerLLodiMMoliereSKurtzJEMathelinCMedical treatment of mammary desmoid-type fibromatosis: which benefit?World J Surg Oncol20171518628420393
- PalassiniEFrezzaAMMarianiLLong-term efficacy of methotrexate plus vinblastine/vnorelbine in a large series of patients affected by desmoid-type fibromatosisCancer J2017232869128410293
- ParkKHChoiYJKimKWCombination chemotherapy with methotrexate and vinblastine for surgically unresectable, aggressive fibromatosisJpn J Clin Oncol201646984584927365524
- PruksakornDLorsomradeeSPhanphaisarnASafety and efficacy of intralesional steroid injection for aggressive fibromatosisWorld J Surg Oncol201715119529096658